Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
David Spector
Cold Spring Harbor Laboratory, Department: Na
Should you be removed from our database? Contact us at [email protected]. Read more below.
ISIS Pharmaceuticals
Payment for services (e.g., consulting fees, honoraria, paid authorship)
Dr. Spector and ISIS Pharmaceuticals share reagents in a collaborative research project that focuses on a molecule that is an aim of the aforementioned grant.
Cold Spring Harbor Laboratory Cancer Research Center
RELEVANCE (See instnjctions): The Program is focused on key oncogenic mechanisms and understanding the vulnerabilities that these lesions create. As such the Project will contribute to our overall understanding of cancer and identify therapeutic targets whose inhibition may lead to the selective targeting of cells with certain cancer genotypes. It will also continue to develop innovative technologies and approaches that will influence cancer research beyond realization of the specific Program goals.
Filed on April 08, 2013.
Tell us what you know about David Spector's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “David Spector”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| David Spector | Cold Spring Harbor Laboratory | Conflict of Interest | Ionis Pharmaceuticals | $20,000 - $39,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.